INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in UnitedHealth Group Inc. to Contact Law Firm

Core Viewpoint - The investigation by Moore Law, PLLC into UnitedHealth Group, Inc. centers on potential claims related to insider trading and antitrust violations stemming from the company's acquisition of Change Healthcare [2][3]. Group 1: Antitrust Investigation - The U.S. Department of Justice (DOJ) filed a lawsuit on February 24, 2022, challenging UnitedHealth's acquisition of Change Healthcare, alleging it would violate antitrust laws [2]. - On February 27, 2024, the Wall Street Journal reported that the DOJ re-opened its antitrust investigation into UnitedHealth, focusing on the relationships between the company's various segments, including Optum [2]. Group 2: Insider Trading Allegations - UnitedHealth was aware of the DOJ investigation since at least October 2023 but did not disclose this information to investors, leading to significant insider selling [3]. - Insiders sold over $120 million of their UnitedHealth shares, with Chairman Stephen Hemsley selling over $102 million and CEO Brian Thompson selling over $15 million [3]. Group 3: Whistleblower Program - The SEC Whistleblower program allows whistleblowers to receive rewards of up to 30 percent of any successful recovery made by the SEC for providing original information [3].